We are entrepreneurs. 100% dedicated and engaged. We initiate and build new digital healthcare solutions and take them to the market. In close collaboration with leading healthcare enterprises, we invest in cases we truly believe in and scale the venture to grow the digital healthcare ecosystem.
Delivering outcome-based care and beyond the pill solutions is hard!
Talents driving digitization are limited and healthcare processes and organizations often struggle with flexible and agile approaches used in digital development. On the other hand, best practices and techniques from other industries do not perform in healthcare. The organizational structures of healthcare companies often encounter resistance to the flexible and agile approaches that are needed for digital development and integration. We founded Evoleen to solve these problems and make digital healthcare happen.
We have created an ecosystem that is unique. By hosting different ventures under the same roof, we achieve a high spillover effect and can benefit from synergies by leveraging our learnings from our digital healthcare ventures.
The Evoleen business model is designed to promote true entrepreneurship. We all participate directly on our venture and take full ownership from day one.
We share risks, we invest and we participate. We only pursue ideas and initiate ventures that we truly believe in. No consulting, just entrepreneurship.
We collaborate with our industry partner from day one and develop our venture together, so that entrepreneurship and corporate experience come together to create real value.
Instead of planning a conventional one-time hand-over of the startup’s value at the end of the journey, we identify with our partner points along the way that allow us to develop the market as early as possible.
Evoleeners are not only entrepreneurs at heart but also well experienced within the corporate environment. We combine the speed and agility of the fast-paced startup world with the expertise of global corporate market leaders.
June 2023 – The Swiss medical device company machineMD and the Swiss digital health expert Evoleen announce their strategic partnership. MachineMD is developing neos™, a non-invasive diagnostic device intended to provide an automatic and quantitative full neuro-ophthalmic work-up. Evoleen drives the software development, focusing on the development and maintenance of the cloud infrastructure and web application.
Eye and pupil movements are sensitive biomarkers for brain disorders. Today, neuro-ophthalmic examinations are usually performed manually. They are time-consuming, require well-trained specialists and the results are mostly qualitative. A new generation of diagnostic tools is needed to perform a fast, high-quality, automated, and easy-to-use examination of brain function that provides quantifiable and reproducible data. The device, called neos™, will be able to provide an automated neuro-ophthalmic examination in less than 10 minutes, and can be used by a healthcare practitioner without specialized training.
Neos™ leverages the latest technical advances in eye tracking via VR headsets, combined with machineMD’s proprietary examination protocols. The cloud solution plays an important role in enabling the telemedicine application – a major advantage of the solution. Thanks to this cloud, the data provided by neos ™ can be made accessible to specialists and healthcare practitioners all over the world.
“We have been looking for a software development partner who is working in a highly regulated environment, while still working in an agile way,” said Dominic Senn, CEO of machineMD. “At Evoleen, we found a high level of technical expertise in setting up and running a medical cloud.”
Evoleen co-creates with partners eHealth opportunities and builds and scales its own ventures. At the same time, Evoleen’s tech experts develop digital health solutions for their own ventures and for external companies. In the strategic partnership with machineMD, Evoleen sees an interesting potential.
“Strategic partnerships like the one with machineMD allow us to fully leverage our expertise in the digital health space while living our credo ‘making digital healthcare happen’. Together with partners like machineMD we make a true difference in the health space”, explains Marcel Wüthrich, Head of Global Business Development at Evoleen.
Evoleen is a disruptive eHealth company builder that supports global pharmaceutical and medtech enterprises to build, accelerate and enhance their digital health business. With a unique co-creation approach, Evoleen offers and shares knowledge in all relevant fields to designing and developing digital health businesses covering all competencies of Customer Insights, R&D, Quality Management & Regulatory Affairs, ICT and operations. www.evoleen.com
machineMD is a medical device company, headquartered in Switzerland, that develops innovative solutions to radically improve early detection of brain disorders such as stroke, multiple sclerosis and brain tumors. The company combines Virtual Reality and Artificial Intelligence to empower neurologists and ophthalmologists with reliable diagnostic data. www.machinemd.com